BLOOD 2021: Primary CNS Lymphoma Treated With Contemporary Therapy Can Carry a Favorable Prognosis
Outcomes are favorable compared with those reported in published trials.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.